Nutromics is excited to announce the formation of its Biosensor Advisory Board, featuring the world-renowned expertise of leading scientists from US and Australian institutions. Led by cutting-edge lab-on-a-patch technology, Nutromics is pioneering the world’s first precision diagnostic platform that is revolutionizing the way diagnoses are made.
The board of experts hails from some of the world’s leading academic institutions, including Columbia University, University of California, Johns Hopkins, North Carolina State University, and the University of New South Wales. Representing a diverse range of disciplines, each member brings invaluable insight and experience to the table.
Nutromics is revolutionizing diagnostics with their cutting-edge continuous DNA-based sensing technology, and they’ve assembled a world-class advisory board of the most esteemed experts in the field to help them achieve their goal. Peter Vranes, CEO and co-founder of Nutromics, believes this will help them remain at the forefront of medical innovation.
He said, “Our mission is to revolutionize diagnostics with our novel technology. To achieve this, we need to collaborate with the most experienced experts, and this advisory board represents a major step in that direction.”
Prof Kevin Plaxco, a renowned inventor of Nutromics’ DNA-based sensor technology and distinguished Professor of Chemistry and Biological Engineering at the University of California, Santa Barbara is paving the way for the future of cutting-edge innovation. As the leader of the advisory board, Prof Plaxco is committed to providing pioneering insight and guidance to the development of the rapidly advancing industry.
Professor Kevin Plaxco, a renowned chemist identified by Thomson Reuters as one of the world’s most highly cited scientists, has not only co-authored 260 publications and 12 patents focusing on protein folding, dynamics, and folding-based sensors, but he is also a key supporter of Nutromics, a company that is on a mission to transform diagnostics.
In 2017, when Professor Plaxco first met Nutromics’ co-founders Peter Vranes and Hitesh Mehta, he was immediately captivated by their ambitious vision and has been firmly committed to supporting them ever since.
The talented scientists on Nutromics’ panel are truly pioneers in the field of in-vivo diagnostics. Their wisdom, enthusiasm, and vast experience allow us to stay ahead of the curve and develop next-gen receptors for our sensors.
With their guidance, we can confidently build on our existing knowledge and produce cutting-edge monitoring solutions. Prof. Plaxco’s enthusiasm for their contribution is an assurance that Nutromics is at the forefront of this innovative concept.
Members of the Biosensor Advisory Board include:
Professor Milan Stojanovic of Columbia University is an esteemed organic chemist known for making groundbreaking contributions to the production of functional oligonucleotides. His work has significantly furthered progress in this field, and he is a leading figure in the scientific community for his innovative work and achievements.
Dr. Netzahualcoyotl Arroyo-Curras of Johns Hopkins University School of Medicine is a trailblazer in the field of pharmacology and molecular sciences who leads a dynamic research group on a mission to revolutionize molecular monitoring.
Through his team’s efforts in the development of advanced biosensing technologies, Dr. Arroyo-Curras is creating the possibility of real-time cellular analyses to open up unprecedented possibilities for disease treatments and diagnoses.
Dr Yi Xiao, a renowned Associate Professor in North Carolina University’s Department of Chemistry, is pushing scientific boundaries to further our understanding of biomolecules. Her research focuses on the development of new methods to rapidly isolate and accurately characterize aptamers of the highest quality.
By applying her insights and expertise to such an essential area of biology, Dr Xiao is driving advances in laboratory research with the potential to lead to breakthroughs in medicine and biotechnology.
Prof Justin Gooding of the University of New South Wales is world-renowned for his pioneering work in the area of surface modification, biosensors, functional nanomaterials, cell-based diagnostic devices, and electroanalysis. His work has earned him the status of Scientia Professor, a title reserved for outstanding scholars whose research produces a significant impact both locally and globally.
Netz ARROYO, an advisor to Nutromics Corp. and its affiliates, is proud to partner with the esteemed Johns Hopkins University—a collaboration that speaks to Nutromics Corp.’s dedication to innovation and excellence. This partnership does not constitute or imply any endorsement by Johns Hopkins University.
About Nutromics
Nutromics is revolutionizing diagnostics with its revolutionary LAB ON A PATCHTM, a DNA-based sensor platform. Founded in 2017 by visionary entrepreneurs Peter Vranes and Hitesh Mehta, the technology seamlessly combines multiple DNA-based sensors with microneedles to track essential targets in real-time.
This gives clinicians access to personalized insights and the power to make the most impactful decisions. Backed by US$30 million in funding and driven by a mission to save lives, Nutromics is transforming healthcare by tackling some of the toughest diseases with the highest unmet clinical needs – one patch for every patient.